Olema Pharmaceuticals, Inc. (OLMA)

Olema Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	33.72	68.54	23.7	13.81	338.55	0.07
Short-Term Investments	215.26	193.27	180.72	273.44	0	0
Cash & Cash Equivalents	248.98	261.81	204.42	287.25	338.55	0.07
Cash Growth	33.89%	28.07%	-28.84%	-15.15%	497766.18%	-97.84%
Other Current Assets	3.11	4.71	4.48	3.44	3.59	0.04
Total Current Assets	252.09	266.51	208.9	290.69	342.14	0.1
Property, Plant & Equipment	2.06	2.29	2.5	4.72	0.08	0.03
Other Long-Term Assets	9.55	8.14	4.25	0.54	0.51	0
Total Long-Term Assets	11.6	10.43	6.75	5.26	0.59	0.03
Total Assets	263.69	276.95	215.65	295.95	342.72	0.13
Accounts Payable	7.66	2.7	0.37	0.02	0.72	0.94
Current Debt	1.06	0.99	1.02	0.93	0	0
Other Current Liabilities	17.51	17.94	15.16	8.07	3.87	0.44
Total Current Liabilities	26.22	21.62	16.55	9.02	4.59	1.38
Long-Term Debt	1.15	1.43	1.55	2.36	0	0
Total Long-Term Liabilities	1.15	1.43	1.55	2.36	0	0
Total Liabilities	27.38	23.05	18.1	11.38	4.59	1.38
Total Debt	2.21	2.42	2.57	3.29	0	0
Debt Growth	-3.58%	-5.77%	-22.01%	-	-	-
Retained Earnings	-336.6	-305.63	-208.98	-104.19	-33.09	-10.76
Comprehensive Income	-0.01	0.35	-1.81	-0.15	0	0
Shareholders' Equity	236.32	253.9	197.55	284.57	338.14	-10.59
Net Cash / Debt	246.77	259.39	201.86	283.96	338.55	0.07
Net Cash / Debt Growth	34.36%	28.50%	-28.91%	-16.12%	497766.18%	-97.84%
Net Cash Per Share	4.44	5.73	5.05	7.18	48.22	0.03
Working Capital	225.87	244.89	192.35	281.67	337.55	-1.28
Book Value Per Share	4.25	5.61	4.94	7.20	48.16	-4.08

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).